The trans-zeatin riboside market is projected to grow from USD 142.5 million in 2025 to USD 322.2 million by 2035, at a CAGR of 8.5%. Purity > 97% will dominate with a 62.0% market share, while university laboratories will lead the application segment with a 58.0% share.